The root cause is believed to be 30 years of not trying to clear people’s doubts about vaccine side effects, according to the above article. Nikkei Asia 10/5. The landmark court ruling of 1992 During the 1980s, Japan possessed world-leading vaccine technology for the treatment of chickenpox, encephalitis, and pertussis. These technologies are licensed to the US and other countries. But vaccine development in Japan came to a near complete halt following a 1992 court ruling ordering the government to compensate people for side effects after vaccination. The Japanese people see this as a landmark ruling that opens the way for victims to seek compensation on a broader scale. A Japanese official injects a vaccine against Covid-19. Photo: Reuters. The Japanese government did not appeal the ruling. Vaccination was also no longer mandatory after the government revised the law in 1994. Since then, vaccination rates in Japan have declined as parents become more concerned about side effects. The AIDS crisis also has a negative impact. In 1996, a Japanese health ministry official was convicted of negligent manslaughter following a scandal involving HIV-contaminated blood products. Despite the government’s efforts to hold responsible, the incident still made officials in Japan feel that they would suffer the consequences if anything happened, while the politicians were unharmed. Gaps in policy Japan is currently facing a “vaccine gap”. In the US and Europe, the product licensing process takes only a few years, but in Japan it is more than 10 years. The Japanese Ministry of Health has issued a special license for the Pfizer vaccine to be administered to the elderly, but this licensing process only applies to foreign vaccines. Meanwhile, the US administration has accelerated vaccine development since the 2001 anthrax attack. When there is a public health crisis in the country, the US Department of Health and Human Services will coordinate with other agencies. research institutes and pharmaceutical companies to respond appropriately. The agency also supports development budgets, clinical trials, as well as emergency approvals. The global vaccine market is growing by nearly 7% per year. New vaccines are released every time a new deadly infectious disease emerges, such as Middle East Respiratory Syndrome (MERS) and Ebola. The mRNA technology used in making vaccines has been studied for the past 20 years and is being applied to fight Covid-19. But private companies in Japan can hardly solve this problem alone because of the lack of motivation to promote the development, purchase, or stockpile of vaccines. Japan currently does not have a domestically produced vaccine. Photo: AFP. “There is a gap in the vaccine because there is still a gap in policy,” said Tetsuo Nakayama, a professor at Kitasato University in Tokyo. One can mention the case of UMN Pharma, a Japanese biotech company that uses new technology to develop flu vaccines. UMN Pharma used to spend more than $100 million to build a manufacturing plant, but the company’s application for a license was rejected in 2017. The grounds for the rejection were that the product “lacked clinical importance” compared to vaccines. available. UMN Pharma currently has negative total assets and is owned by Shionogi – another Japanese pharmaceutical company. The vaccine made by UMN Pharma has been approved in the US. This has led one in the Japanese vaccine industry to question whether anyone still wants to make new vaccines in the country. Complicated legal regulations Technology and research talent are also flowing outside of Japan. “Japan has a lot of regulations but it has a weak support system,” said one virus expert. The country has only two research facilities that can handle the most dangerous viruses. But one of the two establishments has only recently reopened because it was previously opposed by the local people. Public Administration Reform Minister Taro Kono was appointed on January 18 as the person in charge of Japan’s vaccination campaign. Photo: Japan Times. Vaccine research in Japan is subject to complicated regulations by many ministries. Experiments involving gene editing are limited to the Cartagena Protocol. This is an international legal document on biosafety management with genetically modified organisms that Japan has approved. Meanwhile, Europe exempts pharmaceutical companies from applying the Cartagena Protocol. The United States has not yet ratified this document. Japanese manufacturers even ignore the domestic market. Takeda Pharmaceutical, for example, has no plans to license its dengue vaccine in Japan. The same thing happened with the vaccine made from tobacco leaves of Mitsubishi Tanabe Pharma company. In the immediate future, Tokyo has quickly appointed a minister in charge of the Covid-19 vaccine. But products made by AnGes, Shionogi, and other Japanese companies are not expected to be approved before 2022.

Predictable death?

After decades of premiere, the mysteries surrounding the death of four film actors are still mentioned by the audience, the most creepy is the departure of the 12-year-old child star at that time, Heather O’Rourke.

It is known that Heather O’Rourke soon shone after playing the female lead Carol Anne of all 3 Poltergeist films. The face is beautiful like a doll but exuding a cold, scary look and the classic line “They are here” in the first film by O’Rourke resonates for the whole film.

Heather O’Rourke’s doll-like beautiful appearance. Photo: IDMB

However, not long ago, O’Rourke died suddenly at the age of 12. At that time, the child actress had to perform a surgery to treat an acute obstruction but died on the operating table. because i had septic shock on February 1, 1988. Many viewers at that time thought that when the events were threaded together, the death of O’Rourke created a curse for the film.

Heather O’Rourke’s death at the age of 12 made the audience regret. Photo: Poltergeist

Specifically, when carefully examining the details in the movie, people suddenly discovered a poster posted on the head of the bed of little girl Carol Anne advertising the Super Bowl XXII football match took place in 1988, the year O’Rourke died. Meanwhile, the film was filmed in 1982.

The poster is said to predict the death of Heather O’Rourke in 1988. Photo: 4plebs

One detail that made the audience even more creepy was that O’Rourke was hospitalized on the same day of the football match and the child actress died in the city of San Diego, where Super Bowl XXII was held.

Sad milestones of the movie

Hollywood’s “brand new” Dominique Dunne, who played Carol Anne’s sister, was the first Poltergeist cast member to die in 1983, shortly after the film premiered.

Actress Dominique Dunne was the first Poltergeist star to die in 1983. Photo: The Sun

According to investigators, Dunne died from being strangled by her evil boyfriend, John Thomas Sweeney. The New York Times news agency that year said that despite receiving emergency care and resuscitation, she did not survive. On the side of the villain, Sweeney, he must admit manslaughter.

The next ill-fated actor is Julian Beck, who plays the film’s scariest soul, the apocalyptic cult leader Kane in Poltergeist II. On September 14, 1985, he passed away after struggling with stomach cancer.

Julian Beck died in 1985 from stomach cancer. Photo: Poltergeist

Next, the Poltergeist film crew continued to receive sad news about the death of actor Will Sampson. It is known that Sampson plays a friendly ghost named Taylor in the second part of Poltergeist. He died on June 3, 1987, at the age of 53, of a chronic degenerative disease.

Will Sampson is also an ill-fated Poltergeist star. Photo: Poltergeist

The departure of the Poltergeist series has caused many rumors of the movie’s “curse” to spread, but everything is just an unfortunate coincidence. In 2015, a project for a re-production of the Poltergeist movie was carried out. At that time, many people have dug up the “curse” of the movie, but in fact, there are not any stars in the 2015 version of the curse.

Minh Hanh (According to The Sun)

.